PMFA
RCEL icon

Plante Moran Financial Advisors’s Avita Medical RCEL Stock Holding History

Plante Moran Financial Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,200
Closed -$21K – 1081
2021
Q3 		$21K Hold
1,200
– – ﹤0.01% 556
2021
Q2 		$25K Hold
1,200
– – 0.01% 521
2021
Q1 		$24K Hold
1,200
– – 0.01% 516
2020
Q4 		$22K Buy
+1,200
New +$26.3K 0.01% 518

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Plante Moran Financial Advisors's RCEL Position: Q4 2021 in Review

Plante Moran Financial Advisors sold out of Avita Medical (RCEL) in Q4 2021, closing a stake of 1,200 shares — an estimated $21K sold.

Plante Moran Financial Advisors first reported a position in RCEL in Q4 2020 and held it in 4 quarters. The position peaked at $25K in Q2 2021. 62 funds tracked by Wall St. Rank hold RCEL as of Q4 2021.

  • Plante Moran Financial Advisors reported no remaining Avita Medical position as of Q4 2021 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 1,200 Avita Medical shares in Q4 2021, an estimated $21K.
  • Plante Moran Financial Advisors first reported a position in Avita Medical in Q4 2020 and held it in 4 quarters.
  • Plante Moran Financial Advisors's Avita Medical position peaked at $25K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Avita Medical as of Q4 2021.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.